# Specified Drug Use-results Survey of Graceptor in Patients With Kidney Transplantation (Switching From Cyclosporine)

> **NCT02160054** · — · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 289 (actual)

## Conditions studied

- the Maintenance Phase After Kidney Transplantation

## Interventions

- **DRUG:** Graceptor®

## Key facts

- **NCT ID:** NCT02160054
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11-15
- **Primary completion:** 2016-03-31
- **Final completion:** 2016-03-31
- **Target enrollment:** 289 (ACTUAL)
- **Last updated:** 2024-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02160054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02160054, "Specified Drug Use-results Survey of Graceptor in Patients With Kidney Transplantation (Switching From Cyclosporine)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02160054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*